Paid tool

rapidai.com

An enterprise clinical AI platform enhancing neurovascular, cardiac, and radiological decision support.

Visitrapidai.com
Intro

What is rapidai.com?

RapidAI is an enterprise clinical AI platform designed to enhance clinical assessment and transform patient care across healthcare networks. Developed with a deep focus on critical neurovascular and cardiac disease states, the platform delivers robust ai solutions that support doctors in interpreting scans such as a ct head or performing an ai ct perfusion scan. It aids clinical teams in recognizing key indicators of stroke, including lvo cta alerts and complex cases requiring lmvo rapid assessment. Under the direction of its parent company, with ischemaview, inc marketing a suite of advanced products, the technology enables lvo ncct ai detection to speed up transfer and treatment decisions. Through the use of advanced tools like rapid mri neuro software and rapid ai imaging suites, clinicians can securely evaluate urgent patient data. The platform's scientific backing is detailed in various resources, including rapid ai cwhite papers and the informative radiolgy rewired podcast, which discuss clinical validation and platform updates.

rapidai.com at a glance
Contact for Pricing26K monthly visitsPaid access
Pricing

rapidai.com Pricing Plans

Compare rapidai.com free options, rapidai.com paid pricing plans, and usage notes before you choose the best way to use this AI tool in 2026.

Contact for Pricing

Pricing updated:Jun 12, 2026

Features

rapidai.com AI Features

Deep Clinical AI: Offers tools for ischemic stroke triage, hemorrhagic bleed assessment, and rapid aneurysm tracking.Rapid Mobile App: Features a mobile DICOM viewer, real-time alerts for suspected cases, and in-app team messaging.Multi-Modality Support: Facilitates advanced imaging reviews, including ct head analysis, lvo cta triage, and MRI processing.Interoperability: Integrates smoothly with hospital EMR systems and existing PACS/workstations.
Pros & Cons

rapidai.com Pros and Cons

Pros

  • Extensive clinical validation with over 700 publications and 25+ clinical trials.
  • FDA-cleared modules covering major neurovascular and vascular conditions.
  • Enables rapid, multi-site care coordination with real-time mobile notifications.

Limitations

  • Enterprise-level implementation requires formal institutional integration.
  • Pricing is not publicly listed and requires direct contact with sales.

rapidai.com FAQ

iSchemaView, Inc. is the corporate entity behind RapidAI. Under the ischemaview, inc brand, the company developed the initial perfusion technologies and continues to market the expanded RapidAI suite globally.